Changjiang Pharmaceutical Group Balans Gezondheid
Financiële gezondheid criteriumcontroles 1/6
Changjiang Pharmaceutical Group has a total shareholder equity of CN¥737.2M and total debt of CN¥787.8M, which brings its debt-to-equity ratio to 106.9%. Its total assets and total liabilities are CN¥3.1B and CN¥2.4B respectively.
Belangrijke informatie
106.9%
Verhouding schuld/eigen vermogen
CN¥787.84m
Schuld
Rente dekkingsratio | n/a |
Contant | CN¥6.74m |
Aandelen | CN¥737.22m |
Totaal verplichtingen | CN¥2.35b |
Totaal activa | CN¥3.09b |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Revenues Not Telling The Story For Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) After Shares Rise 45%
Sep 30Investors Don't See Light At End Of Changjiang Pharmaceutical Group Co., Ltd.'s (SZSE:300391) Tunnel And Push Stock Down 31%
Aug 11Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 29% But Perhaps Not Attractive Enough
Jun 17Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough
Apr 17Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Not Doing Enough For Some Investors As Its Shares Slump 25%
Feb 27Analyse van de financiële positie
Kortlopende schulden: 300391's short term assets (CN¥1.8B) do not cover its short term liabilities (CN¥1.8B).
Langlopende schulden: 300391's short term assets (CN¥1.8B) exceed its long term liabilities (CN¥522.5M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 300391's net debt to equity ratio (106%) is considered high.
Schuld verminderen: 300391's debt to equity ratio has increased from 16.6% to 106.9% over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: 300391 has less than a year of cash runway based on its current free cash flow.
Voorspelling contante baan: 300391 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 46.3% each year